Last reviewed · How we verify

Inavir (laninamivir octanoate hydrate)

Daiichi Sankyo · FDA-approved active Quality 13/100

At a glance

Generic namelaninamivir octanoate hydrate
SponsorDaiichi Sankyo
Drug classlaninamivir
Therapeutic areaInfectious Disease
PhaseFDA-approved

Approved indications

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: